期刊文献+

42例腹膜后纤维化致肾积水患者外科治疗效果分析 被引量:2

The Surgical Treatment of Hydronephrosis Caused by Retroperitoneal Fibrosis(A Report of 42 Cases)
暂未订购
导出
摘要 目的:对腹膜后纤维化肾积水患者外科处理后分析评价治疗效果。方法:回顾性分析2008年3月—2012年12月收治的42例腹膜后纤维化肾积水患者,并根据患者的病情不同分别采用单纯输尿管置管术14例,开放性输尿管腹腔内松解术26例,肾造瘘术2例。观察术后肾积水缓解、肾功能恢复情况并随访。结果:42例腹膜后纤维化肾积水患者中,35例接受外科治疗的患者其临床症状减轻或完全消失,肾功能得到了有效的改善;7例输尿管松解术后患者肾功能未能得到缓解,可能与术中输尿管松解不彻底或长期肾后性梗阻致不可逆性肾性肾功能不全有关。结论:腹膜后纤维化引起肾积水、肾功能不全的治疗原则是尽早解除输尿管梗阻,防止肾积水加重和肾功能的进一步恶化,外科处理效果明显。 Objective To evaluate the surgical treatment effect of hydronephrosis caused by retroperitoneal fibrosis(RPF). Methods The medical records of 42 patients with hydronephrosis caused by retroperitoneal fi brosis from March 2008 to December 2012 were analyzed retrospectively. According to the patienffs condition, solely ureteral catheter was placed in 14 cases, Ureterolysis with intra-peritoneal transposition was underwent in 26 cases and 2 cases underwent percutaneous nephrostomy. The symptom of hydronephrosis and the renal func tion were followed up. Results Different treatments were taken to these 42 patients. The clinical symptoms of 35 patients were relieved or disappeared completely and the renal function had been effectively improved. But the renal functions of 7 patients who were accepted ureterolysis were not relieved. Conclusion The main treatment of retroperitoneal fibrosis is to relief ureteral obstruction and protect the renal function. The effect of surzical treatment is obvious.
出处 《中国中西医结合外科杂志》 CAS 2013年第5期509-510,共2页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
关键词 腹膜后纤维化 肾积水 治疗效果 Retroperitoneal fibrosis hydronephrosis surgical treatment effect
  • 相关文献

参考文献7

二级参考文献48

  • 1覃谦,李洪,王力斌.腹膜后纤维化5例及十二年来国内文献报告424例分析[J].中国临床实用医学,2007,1(9). 被引量:7
  • 2吴仕和,唐云,尹太,臧传波,王建东,李荣.特发性腹膜后纤维化27例诊治分析[J].中华普通外科杂志,2005,20(5):281-282. 被引量:5
  • 3田野,张峰波,杜林栋.腹膜后纤维化的外科治疗[J].中华泌尿外科杂志,2006,27(2):128-130. 被引量:7
  • 4Tan HM,Khoo J,Pang KP.Pancreatitis leading to retroperitoneal fibrosis and ureteric obstruction[J].Med J Malaysia,2003,58 (2):286-289.
  • 5Vaglio A,Buzio C.Chronic periaortitis:A spectrum of diseases[J].Curr Opin Rheumatol,2005,17(1):34-40.
  • 6Moroni G,Del Papa N,Moronetti LM,et al.Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease[J].Kidney Int,2005,68 (2):562-568.
  • 7Vaglio A,Salvarani C,Buzio C.Retroperitoneal fibrosis[J].Lancet,2006,367(9506):241-251.
  • 8Meier P,Gilabert C,Burnier M,el al.Retroperitoneal fibrosis,an unrecognized inflammalory disease.Clinical observations and review of the literature[J].Nephrologie,2003,24(3):173-180.
  • 9Warnatz K,Keskin AG,Uhl M,et al.Immunosuppressive treatment of chronic periaortitis:a retrospective study of 20 patients with chronic periaortitis and a review of the literature[J].Ann Rheum Dis,2005,64(6):828-833.
  • 10Barbalias GA, Liatsikos EN. Idiopathic retroperitoneal fibrosis revisited[J].Int Urol Nephrol, 1999, 31(4):423-429.

共引文献12

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部